A Double-Blind, Placebo-Controlled, Safety Tolerability and Pharmacokinetics Study in Parkinson¿s Disease Participants Treated with Carbidopa/Levodopa and NE3107 Phase 2a
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
BioVie, Inc
Start Date
February 22, 2022
End Date
December 31, 2023
Administered By
Neurology, Movement Disorders
Awarded By
BioVie, Inc
Start Date
February 22, 2022
End Date
December 31, 2023